Positive: gives a definitive timeline.
aiming for a mid year trial start
negative; slower than anticipated
- Forums
- ASX - By Stock
- NEU
- Ann: Type C Meeting granted by FDA for Phelan-McDermid syndrome
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.20%
!
$12.57

Ann: Type C Meeting granted by FDA for Phelan-McDermid syndrome, page-14
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.57 |
Change
0.025(0.20%) |
Mkt cap ! $1.559B |
Open | High | Low | Value | Volume |
$12.61 | $12.68 | $12.34 | $1.640M | 131.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 183 | $12.55 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.57 | 33 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 366 | 12.590 |
3 | 518 | 12.580 |
4 | 1294 | 12.570 |
5 | 1269 | 12.560 |
4 | 1255 | 12.550 |
Price($) | Vol. | No. |
---|---|---|
12.630 | 248 | 2 |
12.640 | 482 | 5 |
12.650 | 643 | 4 |
12.660 | 1410 | 7 |
12.670 | 1422 | 7 |
Last trade - 10.40am 25/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |